Skip to main content
. Author manuscript; available in PMC: 2015 Jun 30.
Published in final edited form as: Vaccine. 2014 May 9;32(31):3982–3988. doi: 10.1016/j.vaccine.2014.04.084

Figure 2.

Figure 2

Figure 2

(a – c) Evolution and resolution of local reactogenicity (erythema, induration, and ulceration) over three months following BCG revaccination in the INH arm and observation arm respectively. Error bars are interquartile range, minimum-maximum range, with median line and outliers.